3,980 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Why Cheesecake Factory (CAKE) is a Top Growth Stock for the Long-Term https://www.zacks.com/stock/news/2233224/why-cheesecake-factory-cake-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2233224 Feb 28, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term https://www.zacks.com/stock/news/2233209/why-doctor-reddy-s-rdy-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2233209 Feb 28, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Nvidia (NVDA) is a Top Stock for the Long-Term https://www.zacks.com/stock/news/2233176/why-nvidia-nvda-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2233176 Feb 28, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Ovintiv (OVV) Tops Q4 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2232824/ovintiv-ovv-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232824 Feb 27, 2024 - Ovintiv (OVV) delivered earnings and revenue surprises of 21.13% and 15.03%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Luxfer (LXFR) Tops Q4 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2232813/luxfer-lxfr-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232813 Feb 27, 2024 - Luxfer (LXFR) delivered earnings and revenue surprises of 350% and 6.91%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Chemed (CHE) Tops Q4 Earnings Estimates https://www.zacks.com/stock/news/2232811/chemed-che-tops-q4-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232811 Feb 27, 2024 - Chemed (CHE) delivered earnings and revenue surprises of 5.60% and 0.26%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Reports Q4 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2232796/lemonade-lmnd-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232796 Feb 27, 2024 - Lemonade (LMND) delivered earnings and revenue surprises of 22.78% and 2.13%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2232781/treace-medical-concepts-tmci-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232781 Feb 27, 2024 - Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of -11.11% and 0.10%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Myriad Genetics (MYGN) Tops Q4 Earnings and Revenue Estimates https://www.zacks.com/stock/news/2232793/myriad-genetics-mygn-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232793 Feb 27, 2024 - Myriad (MYGN) delivered earnings and revenue surprises of 100% and 1.17%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
SoundThinking (SSTI) Reports Q4 Loss, Tops Revenue Estimates https://www.zacks.com/stock/news/2232780/soundthinking-ssti-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2232780 Feb 27, 2024 - SoundThinking (SSTI) delivered earnings and revenue surprises of -350% and 0.30%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
<<<Page 302>